Nishita T
Department of Radiology, Osaka City University Medical School, Japan.
Osaka City Med J. 1998 Jun;44(1):73-83.
Combined therapy with heat-sensitive liposomes as carriers for drugs and local hyperthermia is thought to improve the local control rate. I studied the antitumor effects and concentrations of CDDP encapsulated in heat-sensitive liposomes (LIP-CDDP) in vivo. LIP-CDDP or CDDP-solution was given to 8 week-old male C3H/He mice bearing SCC VII tumors by tail vein injection, and tumors were heated at 40 degrees C or 42 degrees C. The concentration of LIP-CDDP in blood was significantly higher than that of CDDP-solution. The concentration in tumors after heating at 42 degrees C increased with heating time, but the concentration in tumors without heating or after heating at 40 degrees C did not show these changes. After heating at 42 degrees C, antitumor effects of LIP-CDDP were significantly better than those obtained with the use of CDDP-solution. Heating at 40 degrees C did not alter the antitumor effect of LIP-CDDP. Therefore, LIP-CDDP proved to be very effective when combined with local hyperthermia at 42 degrees C.
以热敏脂质体为药物载体并结合局部热疗的联合疗法被认为可提高局部控制率。我研究了热敏脂质体包裹的顺铂(LIP-CDDP)在体内的抗肿瘤作用及浓度。通过尾静脉注射,将LIP-CDDP或顺铂溶液给予8周龄患有SCC VII肿瘤的雄性C3H/He小鼠,并将肿瘤加热至40℃或42℃。血液中LIP-CDDP的浓度显著高于顺铂溶液。42℃加热后肿瘤中的浓度随加热时间增加,但未加热或40℃加热后的肿瘤中的浓度未呈现这些变化。42℃加热后,LIP-CDDP的抗肿瘤作用显著优于使用顺铂溶液时的效果。40℃加热未改变LIP-CDDP的抗肿瘤作用。因此,LIP-CDDP与42℃局部热疗联合使用时被证明非常有效。